This brief review explores the areas of cognitive impairment that have been observed in
cancer patients and survivors, the cognitive assessment tools used, and the management of …

The potentially detrimental effects of cancer and related treatments on cognitive functioning
are emerging as a key focus of cancer survivorship research. Many patients with central …

Objectives: The aim of this review is to stress the importance of cognitive dysfunction in
cancer survivors, and to discuss the way of assessing and managing these troubles in …

Purpose There is evidence that some cancer survivors suffer cognitive impairment after
chemotherapy. Determining if a patient has cognitive impairment is challenging, especially …

A subset of survivors has cognitive impairment after cancer treatment. This is generally
subtle, but may be sustained. In October 2006, the second international cognitive workshop …

Many cancer patients experience impairments of neurocognitive function, including memory
loss, distractibility, difficulty in performing multiple tasks (multitasking), and a myriad of other …

Cognitive dysfunction is an increasingly recognized complication of cancer and its treatment.
Most research in this arena has found that a subset of patients appear to be vulnerable to …

BACKGROUND: Evidence is emerging that some cancer survivors suffer cognitive
impairment after chemotherapy; the cause is unknown. METHODS: Here we review studies …

Cognitive impairment is a debilitating side effect experienced by patients with cancer treated
with systemically administered anticancer therapies. With around 19.3 million new cases of …

Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …